Table of Content - Personalized Medicine Market

The global personalized medicine market is estimated to be valued at USD 81.33 BN in 2024 and is expected to exhibit a CAGR of 9.4% during the forecast period (2024-2031). Personalized medicine aims to tailor healthcare to the individual characteristics of each patient, providing targeted treatment based on genetics, biomarkers, and clinical risk factors. It represents an evolution from a "one-size-fits-all" approach to treatment and disease prevention to a highly customized system that considers individual variability in patients' genes, environments, and lifestyles. Personalized medicine has the potential to reduce adverse drug reactions, enhance treatment efficacy, and improve health outcomes through better-informed medical decisions. With advancements in genetic testing, big data analytics and molecular diagnostics, it enables physicians to genetically profile patients' susceptibility to specific diseases and optimize therapies accordingly. This emerging field is transforming how diseases are diagnosed, treated, and prevented on an individual level.

Market Dynamics:

The personalized medicine market is driven by factors such as rising healthcare costs and drug development costs for pharmaceutical companies, increasing demand for targeted therapies, growing prominence of companion diagnostics, rising focus on precision medicine, and availability of genetic data for research. However, lack of awareness about this approach among patients and physicians, high upfront costs, and regulatory issues hinder the growth of this market. Developing healthcare infrastructure in emerging economies provides significant growth opportunities for market players. Market leaders are investing in big data analytics and collaborating with diagnostic testing companies to develop combination products for better patient outcomes. Continued research in pharmacogenomics and companion diagnostics will further expand the capabilities of personalized medicine over the next decade.

Key Features of the Study:

This report provides an in-depth analysis of the global personalized medicine market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized medicine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Precision Biologics, Danaher Corporation, Abbott, Illumina, Inc., Exact Sciences Corporation, ASURAGEN, INC., Exagen Inc., Genentech, Inc., Berg Health, Omada Health, Natera, Invitae, Myriad Genetics, Celcuity, InsightRX, and Axial3D
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine market

Detailed Segmentation-

Application:
- Therapeutics
- Nutrition & Wellness
- Diagnostics
- Others
Indication:
- Oncology
- Immunology
- Neurology
- Cardiology
- Autoimmune Diseases
- Others
End User:
- Hospital & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Precision Biologics
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Application
  - Market Snapshot, By Indication
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
Global Personalized Medicine Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
Global Personalized Medicine Market, By Application, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Therapeutics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Nutrition & Wellness
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Diagnostics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Personalized Medicine Market, By Indication, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Oncology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Immunology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Neurology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Cardiology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Autoimmune Diseases
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Personalized Medicine Market, By End User, 2019 – 2031, (USD BN)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Hospital & Clinics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Diagnostic Laboratories
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Academic & Research Institutes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Global Personalized Medicine Market, By Region, 2019 – 2031, (USD BN)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2020–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Precision Biologics*
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Danaher Corporation
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Abbott
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Illumina, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Exact Sciences Corporation
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - ASURAGEN, INC.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Exagen Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Genentech, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Berg Health
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Omada Health
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Natera
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Invitae
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Myriad Genetics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Celcuity
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - InsightRX
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Axial3D
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 28 market data tables and 34 figures on “Personalized Medicine Market” - Global forecast to 2031

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount